Real-world data of EGFR minor mutated NSCLC treated with EGFR-TKI: Comparative analysis including compound mutation and de novo T790M mutation

被引：0

作者：

Tanaka, K. ^{[1
]}

Inui, N. ^{[2
]}

Asada, K. ^{[3
]}

Abe, T. ^{[4
]}

Hataji, O. ^{[5
]}

Hayai, S. ^{[6
]}

Ito, K. ^{[5
]}

Imaizumi, K. ^{[7
]}

Kimura, T. ^{[8
]}

Kubo, A. ^{[9
]}

Kunii, E. ^{[10
]}

Murotani, K. ^{[11
]}

Okuno, M. ^{[12
]}

Oya, Y. ^{[13
]}

Shindoh, J. ^{[4
]}

Taniguchi, H. ^{[14
]}

Tsuda, T. ^{[14
]}

Yamaguchi, T. ^{[13
]}

Hida, T. ^{[13
]}

Suda, T. ^{[1
]}

机构：

[1] Hamamatsu Univ Sch Med, Internal Med 2, Hamamatsu, Shizuoka, Japan

[2] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapuet, Hamamatsu, Shizuoka, Japan

[3] Shizuoka Prefectural Gen Hosp, Dept Resp, Shizuoka, Japan

[4] Ogaki Municipal Hosp, Dept Resp Med, Ogaki, Japan

[5] Matsusaka City Hosp, Resp Ctr, Matsusaka, Japan

[6] Chutoen Gen Med Ctr, Dept Resp Med, Kakegawa, Japan

[7] Fujita Hlth Univ, Dept Resp Med, Toyoake, Aichi, Japan

[8] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Japan

[9] Aichi Med Univ, Div Resp Med & Allergol, Nagakute, Aichi, Japan

[10] Nagoya City West Med Ctr, Dept Resp Med, Resp Tract Oncol Ctr, Nagoya, Aichi, Japan

[11] Kurume Univ, Grad Sch Med, Biostat Ctr, Kurume, Fukuoka, Japan

[12] Aichi Hosp, Aichi Canc Ctr, Dept Resp Med, Okazaki, Aichi, Japan

[13] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan

[14] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

521P

引用

页数：1

共 50 条

[21] EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib
Hochmair, Maximilian
Holzer, Sophia
Filipits, Martin
Mohn-Staudner, Andrea
Errhalt, Peter
Absenger, Gudrun
Bundalo, Tatjana
Arns, Madeleine
Setinek, Ulrike
Mikes, Romana
Kolb, Rainer
Schumacher, Michael
Zoechbauer-Mueller, Sabine
Patocka, Kurt
Haslbauer, Ferdinand
Rudzki, Jakob
Burghuber, Otto
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1254 - S1254
[22] EGFR T790M resistance mutation in NSCLC: Real-life data of Austrian patients treated with osimertinib
Holzer, Sophia
Hochmair, Maximilian
Filipits, Martin
Mohn-Staudner, Andrea
Errhalt, Peter
Absenger, Gudrun
Bundalo, Tatjana
Arns, Britt-Madelaine
Setinek, Ulrike
Mikes, Romana
Kolb, Rainer
Schumacher, Michael
Zoechbauer-Mueller, Sabine
Patocka, Kurt
Haslbauer, Ferdinand
Rudzki, Jakob
Burghuber, Otto Chris
WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (19-20) : 769 - 770
[23] Influence of plasma T790M mutation on clinical decision after 1st generation EGFR-TKI resistance in a Real-world study
Zhang, S.
Zhu, L.
Xia, B.
Chen, X.
Ma, S.
ANNALS OF ONCOLOGY, 2017, 28
[24] The significance of micro-EGFR T790M mutation on EGFR-TKI efficacy in patients with NSCLC: The WJOG13119L study.
Sato, Yuki
Masuda, Takeshi
Miura, Satoru
Tachihara, Motoko
Hosokawa, Shinobu
Nakamura, Atsushi
Miyawaki, Taichi
Yoshimine, Kohei
Mori, Masahide
Shiraishi, Hideaki
Hamai, Kosuke
Haratani, Koji
Maeda, Sumiko
Tabata, Eriko
Kitagawa, Chiyoe
Tanizaki, Junko
Imai, Takumi
Yamamoto, Nobuyuki
Nakagawa, Kazuhiko
Hattori, Noboru
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[25] De novo EGFR T790M mutation in lung cancer patients harboring sensitive EGFR mutations
Lee, Youngjoo
Lee, Geon Kook
Lee, Yeon-Su
Zhang, Wenji
CANCER RESEARCH, 2014, 74 (19)
[26] Noninvasive monitoring of acquired EGFR-T790M mutation and discovery of its heterogeneity in patients with advanced NSCLC treated with EGFR-TKI
Ye, X.
Zheng, D.
Zhang, M. Z.
Sun, Y.
Wang, J. Y.
Ni, J.
Zhang, H. P.
Zhang, L.
Luo, J.
Zhang, J.
Tang, L.
Su, B.
Chen, G.
Zhu, G. S.
Xu, J. F.
Gu, Y.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 123 - 124
[27] Obesity has an impact on the efficacy of EGFR-TKI in NSCLC patients harbouring EGFR mutation: A real-world study
Ding, Z-Y.
Chen, Y-Y.
Hong, Y.
Tong, L-P.
Li, Q.
Lin, P-P.
ANNALS OF ONCOLOGY, 2019, 30
[28] Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation
Oya, Yuko
Yoshida, Tatsuya
Kuroda, Hiroaki
Shimizu, Junichi
Horio, Yoshitsugu
Sakao, Yukinori
Inaba, Yoshitaka
Hida, Toyoaki
Yatabe, Yasushi
CLINICAL LUNG CANCER, 2017, 18 (06) : 698 - +
[29] Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
Kuiper, J. L.
Heideman, D. A. M.
Thunnissen, E.
Paul, M. A.
van Wijk, A. W.
Postmus, P. E.
Smit, E. F.
LUNG CANCER, 2014, 85 (01) : 19 - 24
[30] EGFR resistant T790M mutation in NSCLC: real-life data of patients treated with AZD9291
Hochmair, M.
Holzer, S.
Setinek, U.
Filipits, M.
Mohn-Staudner, A.
Korger, M.
Fabikan, H.
Pirker, C.
Burghuber, O. C.
WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (19-20) : 831 - 831

← 1 2 3 4 5 →